1. Home
  2. ARGX vs RBLX Comparison

ARGX vs RBLX Comparison

Compare ARGX & RBLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARGX
  • RBLX
  • Stock Information
  • Founded
  • ARGX 2008
  • RBLX 2006
  • Country
  • ARGX Netherlands
  • RBLX United States
  • Employees
  • ARGX N/A
  • RBLX N/A
  • Industry
  • ARGX Biotechnology: Biological Products (No Diagnostic Substances)
  • RBLX EDP Services
  • Sector
  • ARGX Health Care
  • RBLX Technology
  • Exchange
  • ARGX Nasdaq
  • RBLX Nasdaq
  • Market Cap
  • ARGX 40.4B
  • RBLX 43.4B
  • IPO Year
  • ARGX 2017
  • RBLX 2021
  • Fundamental
  • Price
  • ARGX $591.87
  • RBLX $58.29
  • Analyst Decision
  • ARGX Strong Buy
  • RBLX Buy
  • Analyst Count
  • ARGX 20
  • RBLX 23
  • Target Price
  • ARGX $682.00
  • RBLX $62.19
  • AVG Volume (30 Days)
  • ARGX 314.1K
  • RBLX 8.0M
  • Earning Date
  • ARGX 05-08-2025
  • RBLX 05-08-2025
  • Dividend Yield
  • ARGX N/A
  • RBLX N/A
  • EPS Growth
  • ARGX N/A
  • RBLX N/A
  • EPS
  • ARGX 12.78
  • RBLX N/A
  • Revenue
  • ARGX $2,248,205,000.00
  • RBLX $3,601,979,000.00
  • Revenue This Year
  • ARGX $57.86
  • RBLX $48.95
  • Revenue Next Year
  • ARGX $31.90
  • RBLX $20.06
  • P/E Ratio
  • ARGX $43.78
  • RBLX N/A
  • Revenue Growth
  • ARGX 77.22
  • RBLX 28.68
  • 52 Week Low
  • ARGX $352.77
  • RBLX $29.55
  • 52 Week High
  • ARGX $678.21
  • RBLX $75.74
  • Technical
  • Relative Strength Index (RSI)
  • ARGX 42.34
  • RBLX 45.03
  • Support Level
  • ARGX $582.07
  • RBLX $57.10
  • Resistance Level
  • ARGX $598.06
  • RBLX $60.89
  • Average True Range (ATR)
  • ARGX 13.05
  • RBLX 2.41
  • MACD
  • ARGX -0.35
  • RBLX 0.37
  • Stochastic Oscillator
  • ARGX 33.69
  • RBLX 45.99

About ARGX argenx SE

Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.

About RBLX Roblox Corporation

Roblox operates an online video game platform with 80 million daily active users that lets young gamers create, develop, and monetize games (or "experiences") for other players. The firm offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning $3.5 billion in bookings in 2023 through in-game purchases and advertising while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers than creating new games or franchises.

Share on Social Networks: